Showing results (1-10 of 355) with videos related to

Sort By:
Pageof 36
International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancerM J Zelefsky, R X Ginor, Z Fuks, et al.
Seminars in Radiation Oncology|April 29, 1998
Three-dimensional conformal radiotherapy and dose escalation: where do we stand?M J Zelefsky, S A Leibel, G J Kutcher, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvementS A Leibel, Z Fuks, M J Zelefsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancerM J Zelefsky, S A Leibel, K E Wallner, et al.
The American Journal of Surgical Pathology|September 9, 1999
Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissuesP B Gaudin, M J Zelefsky, S A Leibel, et al.
The Journal of Urology|December 1, 1993
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinomaM J Zelefsky, W F Whitmore, S A Leibel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resectionA S Sandhu, M J Zelefsky, H J Lee, et al.
The Cancer Journal From Scientific American|July 1, 1995
The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinomaM J Zelefsky, S A Leibel, G J Kutcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapyM J Zelefsky, O Lyass, Z Fuks, et al.
Pageof 36